ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets 'Undruggable' cancer mutation in major trial
Disease control Recruiting nowThis study is testing an experimental pill called LY3537982 for people with advanced cancers that have a specific genetic change called KRAS G12C. The research aims to find the safest and most effective dose, and see if the drug can shrink tumors in cancers like lung, colon, panc…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
New pill targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is the first study in people to test a new oral medication called NKT3964. The main goals are to find a safe dose and see if the drug shows early signs of shrinking tumors in adults with advanced cancers that have spread and no longer respond to standard treatments. The stud…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New 'Smart Bomb' drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first human trial of a new experimental cancer drug called LY4175408. It is designed to target and deliver a toxic payload specifically to cancer cells that have a certain marker (PTK7). The study will test the drug's safety, side effects, and early signs of effective…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
UK trial repurposes cancer drug to fight rare tumors
Disease control Recruiting nowThis trial is testing if an existing immunotherapy drug called atezolizumab can help control rare cancers or common cancers with rare genetic features. It will involve about 30 adults and children whose cancers have specific genetic markers. The goal is to see if this approved dr…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Early trial tests 'Smart Bomb' radiation for tough cancers
Disease control Recruiting nowThis study is testing a new targeted radiation treatment called LY4257496 for people with advanced cancers that have a specific protein (GRPR). The main goals are to find a safe dose and see if the treatment helps shrink tumors. It is for adults with certain advanced breast, pros…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New 'Smart Bomb' drug enters human testing for multiple advanced cancers
Disease control Recruiting nowThis is the first study in people to test a new targeted cancer drug called LY4170156. It aims to find a safe dose and see if it can help control advanced cancers, including ovarian, lung, breast, and pancreatic cancers. The study will also test the drug in combination with other…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
New cancer drug enters first human trials for multiple tumor types
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called DM002 for people with advanced solid tumors including ovarian, prostate, endometrial, and colorectal cancers. The study has two parts: first finding the safest dose, then testing that dose to see how well it work…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC
-
Major cancer registry launches to map Real-World treatment paths
Knowledge-focused Recruiting nowThis study is a national registry that will follow nearly 2,000 patients in Germany with advanced ovarian or endometrial cancer for up to three years. Its purpose is to document the real-world treatments patients receive, track how the disease progresses, and measure their qualit…
Matched conditions: ENDOMETRIAL NEOPLASMS
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC